210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Hematological Oncology · 2025-06 · 43 (S3)
DOI: 10.1002/hon.70094_210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 16.06.2025. Verfasst von R. Jacobs und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jacobs, R., Wang, X., Fu, Q., Yuan, D., Beuge, D. V., Maglinte, G. A., Seymour, E. K., & Shadman, M. (2025). 210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Hematological Oncology, 43(S3). https://doi.org/10.1002/hon.70094_210
Vancouver
Jacobs R, Wang X, Fu Q, Yuan D, Beuge DV, Maglinte GA, et al. 210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Hematological Oncology. 2025;43(S3). doi:10.1002/hon.70094_210
BibTeX
@article{Jacobs2025,
author = {Jacobs, R. and Wang, X. and Fu, Q. and Yuan, D. and Beuge, D. van and Maglinte, G. A. and Seymour, E. K. and Shadman, M.},
title = {210 | REAL‐WORLD COMPARATIVE EFFECTIVENESS OF FIRST‐LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA},
journal = {Hematological Oncology},
year = {2025},
volume = {43},
number = {S3},
doi = {10.1002/hon.70094_210}
}
EUVIMED